Literature DB >> 9258910

Cellular distribution of NMDA glutamate receptor subunit mRNAs in the human cerebellum.

C R Scherzer1, G B Landwehrmeyer, J A Kerner, D G Standaert, Z R Hollingsworth, L P Daggett, G Veliçelebi, J B Penney, A B Young.   

Abstract

We have used a quantitative in situ hybridization method with human ribonucleotide probes to examine the regional and cellular distribution of N-methyl-D-aspartate receptor (NMDAR) subunit mRNAs in the human cerebellum. Purkinje cells showed very dense labeling for NMDAR1 mRNA, dense labeling for NMDAR2A mRNA, and moderate labeling for NMDAR2D mRNA, whereas labeling for NMDAR2C mRNA was low. Granule cells showed high hybridization signals for the NMDAR1 and NMDAR2C mRNAs and moderate signals for the NMDAR2A and NMDAR2D mRNAs. In addition intense labeling with the NMDAR2B probe was observed in medium-sized neurons with chromophilic cell bodies in the upper part of the granule cell layer, most likely representing Golgi cells. Neurons in the molecular layer, i.e., basket cells and stellate cells, showed moderate hybridization signals for NMDAR1 and NMDAR2D and low signal for NMDAR2C. Each type of cerebellar neuron analyzed displayed a distinct NMDAR2 subunit profile, suggesting that they are likely to have NMDA receptors with distinct properties.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9258910     DOI: 10.1006/nbdi.1997.0136

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  8 in total

1.  Climbing-fibre activation of NMDA receptors in Purkinje cells of adult mice.

Authors:  Massimiliano Renzi; Mark Farrant; Stuart G Cull-Candy
Journal:  J Physiol       Date:  2007-09-27       Impact factor: 5.182

Review 2.  The kynurenine pathway and the brain: Challenges, controversies and promises.

Authors:  Robert Schwarcz; Trevor W Stone
Journal:  Neuropharmacology       Date:  2016-08-07       Impact factor: 5.250

Review 3.  The N-methyl D-aspartate receptor glycine site and D-serine metabolism: an evolutionary perspective.

Authors:  Michael J Schell
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2004-06-29       Impact factor: 6.237

Review 4.  Neurodegeneration in Multiple Sclerosis: Symptoms of Silent Progression, Biomarkers and Neuroprotective Therapy-Kynurenines Are Important Players.

Authors:  Dániel Sandi; Zsanett Fricska-Nagy; Krisztina Bencsik; László Vécsei
Journal:  Molecules       Date:  2021-06-05       Impact factor: 4.411

Review 5.  The role of the cerebellum in schizophrenia: from cognition to molecular pathways.

Authors:  Peyman Yeganeh-Doost; Oliver Gruber; Peter Falkai; Andrea Schmitt
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

Review 6.  Kynurenines in the Pathogenesis of Multiple Sclerosis: Therapeutic Perspectives.

Authors:  Tamás Biernacki; Dániel Sandi; Krisztina Bencsik; László Vécsei
Journal:  Cells       Date:  2020-06-26       Impact factor: 6.600

7.  Pediatric anti-NMDA receptor encephalitis associated with COVID-19.

Authors:  Esra Sarigecili; Ilknur Arslan; Habibe Koc Ucar; Umit Celik
Journal:  Childs Nerv Syst       Date:  2021-04-14       Impact factor: 1.532

8.  Gene expression of NMDA receptor subunits in the cerebellum of elderly patients with schizophrenia.

Authors:  Andrea Schmitt; Jiri Koschel; Mathias Zink; Manfred Bauer; Clemens Sommer; Josef Frank; Jens Treutlein; Thomas Schulze; Thomas Schneider-Axmann; Eleni Parlapani; Marcella Rietschel; Peter Falkai; Fritz A Henn
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-05-12       Impact factor: 5.270

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.